logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
B

Bianjiang Liu

the first affiliated hospital with nanjing medical university
H指数:20
被引数:1,157

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: SLC7A11 upregulation via AR and NEDD4L ubiquitination contributes to ferroptosis inhibition and enzalutamide resistance in castration-resistant prostate cancer

更正：通过AR和NEDD4L泛素化上调SLC7A11，促进铁死亡抑制和恩扎卢胺耐药性在去势抵抗性前列腺癌中的作用

Cell Death & Disease
IF9.6
2026-05-050
OAAI
Min Tang; Luotong Xue; Bao Wang; Zhixin Jiang; Pu Li; Hengtao Bu; Chesong Zhao; Yurong Zhang; Shuaimei Liu; Xiyuan Chen; Bianjiang Liu; Xiaoxin Meng; Jie Li
Correction: SLC7A11 upregulation via AR and NEDD4L ubiquitination contributes to ferroptosis inhibition and enzalutamide resistance in castration-resistant prostate cancer

更正：通过AR和NEDD4L泛素化介导的SLC7A11上调，促进了铁死亡抑制以及恩扎卢胺耐药在去势抵抗性前列腺癌中的发生。

Cell Death & Disease
IF9.6
2025-11-180
OA
Min Tang; Luotong Xue; Bao Wang; Zhixin Jiang; Pu Li; Hengtao Bu; Chesong Zhao; Yurong Zhang; Shuaimei Liu; Xiyuan Chen; Bianjiang Liu; Xiaoxin Meng; Jie Li
SLC7A11 upregulation via AR and NEDD4L ubiquitination contributes to ferroptosis inhibition and enzalutamide resistance in castration-resistant prostate cancer

通过AR和NEDD4L泛素化介导的SLC7A11上调，促进了铁死亡抑制以及恩扎卢胺耐药性在去势抵抗性前列腺癌中的发生。

Cell Death & Disease
IF9.6
2025-08-050
OA
Min Tang; Luotong Xue; Bao Wang; Zhixin Jiang; Pu Li; Hengtao Bu; Chesong Zhao; Yurong Zhang; Shuaimei Liu; Xiyuan Chen; Bianjiang Liu; Xiaoxin Meng; Jie Li

研究方向

暂未获取到该数据
Z
Zengjun Wang
H 指数:0论文数:2被引数:2
S
Shifeng Su
H 指数:17论文数:81被引数:728
C
Chenkui Miao
H 指数:17论文数:66被引数:961
H
Hengtao Bu
H 指数:7论文数:15被引数:223
A
Aiming Xu
H 指数:24论文数:92被引数:1,919
Y
Yankang Cui
H 指数:5论文数:21被引数:150
C
Chao Qin
H 指数:43论文数:344被引数:7,076
C
Chao Liang
H 指数:13论文数:32被引数:436
Z
Zengjun Wang
H 指数:18论文数:62被引数:1,085
M
Min Tang
H 指数:18论文数:60被引数:828